在Tarlatamab治疗开始后,疾病的快速进展和水头:一个病例报告
Doppo Fukui1, Jun Sakakibara-Konishi1,2, Riku Azuma1
1Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Respiratory medicine case reports
|November 28, 2025
概括
塔拉塔马布对小细胞肺癌 (SCLC) 具有前景,但这种病例显示出可能导致疾病迅速进展和神经毒性. 在治疗期间,仔细监测患者至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 神经瘤学神经瘤学
背景情况:
- 塔拉塔马布是一种双特异性T细胞参与剂,在小细胞肺癌 (SCLC) 中表现出有效性.
- 在tarlatamab治疗期间疾病进展的模式仍未得到充分研究.
- 免疫效应细胞相关神经毒性综合征 (ICANS) 是一个已知的不良事件.
研究的目的:
- 在广泛阶段的SCLC中,在Tarlatamab开始后报告急性疾病进展的病例.
- 为了调查模仿ICANS的神经症状的原因.
主要方法:
- 一个71岁的男性患者的病例报告,患有扩散阶段的SCLC.
- 塔拉他马布 (tarlatamab) 后的临床观察和诊断评估.
- 评估不良事件,包括ICANS和疾病进展.
主要成果:
- 患者经历了快速的SCLC进展,由于大脑转移而导致阻塞性水脑.
- 神经症状归因于脑水,而不是ICANS.
- 塔拉塔马布治疗与急性,快速的瘤进展和患者衰退有关.
结论:
- 这一案例凸显了tarlatamab治疗期间疾病迅速进展的可能性.
- 区分快速进展和ICANS需要进行彻底的诊断评估.
- 密切的患者随访对于管理潜在的快速瘤进展及其后果至关重要.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.7K
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
1.5K
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cholera
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
